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Abstract 
Scanning electron microscopy (SEM) was 
used to elucidate the mechanism of polymer 
degradation and drug release in polyanhydride 
microspheres . Three different fabrication 
methods solvent removal, solvent 
evaporation, and hot melt microencapsulation -
were used to prepare polyanhydride 
microspheres containing a variety of drugs . The 
morphology of these microspheres releasing 
drug in vitro and in vivo was studied by SEM 
and compared with degradation and release 
data measured by conventional methods. 
Microspheres prepared by the three techniques 
were shown to have distinctive morphological 
characteristics induced by the nature of the 
fabrication method . In addition, SEM analysis 
could be used to explain the drug release 
profiles and polymer degradation behavior 
seen in vitro as well as the in vivo effects of 
insulin-loaded microspheres on diabetic rats. 
This study has shown SEM to be an important 
and powerful tool for analyzing the effects of 
microsphere fabrication method on drug 
release. 
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Introduction 
Polyanhydrides are one of the very few 
synthetic bioerodible polymers that are being 
utilized as implantable substances in humans 
(Chasin et al., 1988). Hydrophobic 
polyanhydride slabs have been found to erode 
heterogeneously in aqueous media , thereby 
displaying surface erosion (Leong et al., 1985) . 
This was attributed to a combination of the 
very labile anhydride bond and the very 
hydrophobic nature of the polyanhydrides 
studied. Water cannot easily penetrate into the 
hydrophobic polymer matrix, so degradation 
occurs principally on the surface, where the 
anhydride bonds are hydrolyzed. Although a 
slab which displays surface erosion ( Leong et 
al., 1985) would be of considerable utility in 
controlled drug delivery , this is not always a 
desired geometry. In many cases, micro spheres 
have been of considerable interest in the 
development of controlled release systems and 
other applications; in addition, microspheres 
that display surface erosion have yet to be 
developed. With this objective in mind, the 
overall goal of this work was to develop 
polyanhydride microspheres, to characterize 
their internal and surface morphology, study 
the type of erosion that takes place and 
determine the possibility of using them to 
release macromolecules such as insulin. In this 
study, it is shown that morphological 
evaluation of microspheres by SEM is an 
important approach in the evaluation of 
microencapsulation techniques, thereby 
resulting in delivery systems that can be 
tailored to achieve a variety of desired 
characteristics. 
E. Mathiowitz, D. Kline, and R. Langer 
Materials and Methods 
Polymer Preparation 
Sebacic acid (SA), 1,3-bis(p-carboxy-
phenoxy)propane (CPP) and 1, 12-dodecanedioic 
acid (DD) (Aldrich) were used as monomers in 
the synthesis of polyanhydride homopolymers 
and copolymers as previously described (Domb 
et al., 1987). Copolymers are referred to by 
their monomer abbreviations followed by their 
molar percentage in the reaction mixture, e.g. a 
copolymer of CPP and SA in a 20:80 molar 
proportion is termed P(CPP-SA) 20:80. 
Molecular weights of synthesized polymers 
were measured by gel permeation chroma-
tography as described previously (Domb et al., 
1987); all the polyanhydrides had weight 
average molecular weights between 25K and 
40K. Infrared spectroscopy (film cast onto NaCl 
plates) of all the polymers revealed typical 
anhydride absorbances at 1720 and 1 780 cm- 1 . 
Microsphere Preparation 
Micro spheres were prepared using three 
encapsulation methods: 
(i) Solvent evaporation. In this method 
the polymer is dissolved in a volatile organic 
solvent, the drug (either soluble or dispersed as 
fine particles) is added to the solution, and the 
mixture is suspended in an aqueous solution 
that contains a surface active agent such as 
poly(vinyl alcohol) . The resulting emulsion is 
stirred until most of the organic solvent 
evaporates, leaving solid microspheres (Beck et 
al., 1979; Benita et al., I 984; Jaffe H., 1981) In 
the present work the method was used with 
the following modifications: the polyanhydride 
P(CPP-SA) 50:50 was dissolved in methylene 
chloride. Two different polymer concentrations 
were used (0.05 and 0.20 g/ml). The solution 
was loaded with drug and suspended in 200 ml 
of vigorously stirring distilled water containing 
1 % (w/v) poly(vinyl alcohol) (Sigma) . After 4 
hours of mixing, the microspheres were washed 
with water and dried overnight in a lyophilizer. 
(ii) Hot melt microencapsulation. In this 
method the polymer is first melted and then 
mixed with the solid particles of the dye or 
drug that have been sieved to less than 50 µm 
(Mathiowitz and Langer, 1987). The mixture is 
suspended in a non-miscible solvent (like 
silicon oil) that is heated 5°C above the melting 
point of the polymer and stirred continuously. 
Once the emulsion is stabilized, it is cooled until 
the polymer particles solidify. The 
microspheres are washed by decantation with 
petroleum ether to give free-flowing powders . 
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(iii) Solvent removal. In this nethod, the 
drug is dispersed or dissolved in a solution of 
the polymer in a volatile organic solvent like 
methylene chloride. This mixture is then 
suspended with stirring in an organic oil (such 
as silicon oil), forming an emulsion. Unlike 
solvent evaporation, however, where the 
dispersed solvent is insoluble in the continuous 
aqueous phase, the solvent removal technique 
allows the slightly oil-soluble volatile solvent to 
be slowly extracted into the oil, thus leaving 
behind polymer microspheres. This new 
method permits the preparation of 
microspheres from polymers with high melting 
points, including polymers which were more 
hydrophobic than those previously used 
(Mathiowitz and Langer, 1987). Microspheres 
were prepared unloaded (blank) and with 
three different drugs: Zn-insulin (Eli Lilly), acid 
orange 8 (Aldrich) and acetylsalicylic acid 
(Aldrich). 
Scannini: Electron Microscopy 
Morphology of polymers was studied on a 
scanning electron microscope (ISi Model DS-
130 and Hitachi S-530) using 15 and 20 kV. 
Cross-sections of samples were obtained by 
embedding the microspheres in mounting 
media (Histo Prep SO-H-75 Frozen Tissue 
Embedding Media, Fisher Scientific) and cutting 
10 µ m sections at -20°C with a microtome 
(International Equipment Company). Samples 
for SEM were freeze-dried, mounted on metal 
stubs with double-sided tape, and sputter-
coated with gold-palladium under argon gas 
(Cold Polaron Instrument ES I 00 was used). The 
samples were coated for 30 or 60 seconds (two 
pulses of 30 seconds each were given to the 
more porous systems; 30 sec coating results in 
50 AO gold thickness), using voltage of 2.5 kV 
and a current of 18 mA. 
In Vitro Dei:radation Studies 
Polyanhydride microspheres contarnrng 
Zn-insulin or acid orange were separated into 
different size ranges using standard sieves 
(Newark Wire Cloth Co). Release experiments 
were conducted in 10 to 50 ml aliquots of 0.1 
M, pH 7.4 phosphate buffer at 37°C in small 
columns (Bio-Rad polypropylene Economo-
column, 10 and 50 ml). Gentamicin sulfate 
(Sigma) was used as an antibacterial agent in 
the buffer at a concentration of 0.05 mg/ml. 
The buffer was changed periodically to assure 
perfect sink conditions. The polymer erosion 
and acid orange release were followed by 
measuring the absorbance of the release buffer 
Morphology of Polyanhydride Microsphere 
at 490 nm for the acid orange and at 247 nm 
for the polymer erosion products (Mathiowitz 
and Langer, 1987) with a Perkin-Elmer UV 
spectrophotometer. An in vitro Bio-rad protein 
assay was employed to measure insulin 
concentrations in the release buffer 
(Mathiowitz et al., 1988). 
In Vivo Studies With Diabetic Rats 
Biological activity of insulin released from 
microspheres was determined in vivo by 
monitoring daily blood and urine glucose levels 
in polymer-implanted diabetic female Sprague-
Dawley rats. Diabetes was previously induced 
with a tail vein injection of 65 mg/kg of 
streptozotocin (Upjohn) in pH 4.5, O. lM citrate 
buffer, the optimal dose for inducing diabetes 
in these rats (Brown et al., 1983). When serum 
glucose levels reached a minimum of 400 
mg/di the rats were considered diabetic and 
were treated with the insulin-loaded 
polyanhydride microspheres. Daily urine 
glucose outputs were estimated with 
Chemstrips UG (Bio-Dynamics) . Blood was 
drawn daily from the tail vein and serum 
glucose levels were read on a YSI Model 23A 
Glucose Analyzer. 
Dry microspheres were implanted 
subcutaneously through a small (1 cm) surgical 
incision in the skin of the dorsum of the rat and 
the skin was closed with 5-0 Ethilon 
monofilament nylon sutures (Ethicon). Where 
indicated, certain microspheres were injected 
in an aqueous suspension in 0.1 M pH 7.4 
phosphate buffer through a 22 gauge needle 
(bigger microspheres were implanted). Three 
groups were studied: healthy rats, diabetic 
control rats and diabetic rats that were 
implanted with the drug- loaded spheres. 
In Vivo De1:radatioo Studies 
In vivo degradation studies were 
performed after implanting or injecting blank 
microspheres as described above. Rats were 
sacrificed sequentially on days 6, 10 and 46 by 
CO2 overdose. Microspheres were isolated from 
tissue samples, the polymer itself was freeze 
dried, lyophilized, cross-sectioned with a blade, 
coated with gold and analyzed by SEM as 
described before. 
Results And Discussion 
Polymer Characteristics 
The first step in the development of any 
type of delivery system is understanding the 
physical properties of the polymer from which 
it is formed. Chemical structures of the various 
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Rl, R2 could be any of the following: 
n=8 Sebacic acid (SA) 
n= 10 Dodecanedioic acid (DD) 
-OO-(CH2),-0-0 
(p-Carboxyphenoxy)propane (CPP) 
Figure 1. Chemical structure of polyanhydrides. 
polyanhydrides used in this study are shown in 
Figure 1. They are composed of aliphatic 
monomers, such as sebacic acid, and aromatic 
monomers, such as CPP. Homopolymers of the 
aliphatic monomers degrade rapidly (1 to 6 
days depending on the size of the device), are 
soluble in organic solvents (Mathiowitz et al., 
1988), have low melting points (Domb et al., 
1987) and glass transition at 60°C (Mathiowitz 
et al, 1989), and their degradation products 
have good solubility in aqueous solutions 
(Mathiowitz et al., 1988). Polymers made of 
aromatic monomers (Figure 1) degrade much 
more slowly (weeks to years), are insoluble in 
organic solvents (Mathiowitz et al., 1988), have 
high melting points (Domb et al., 1987) and 
glass transition at 96°C (Conix, 1958) and their 
degradation products have low aqueous 
solubility. Copolymers made of aliphatic and 
aromatic monomers degrade in aqueous 
enviroments in times that range from one day 
to several weeks, are soluble in organic 
solvents (Mathiowitz et al., 1988), and their 
melting point and the solubility of the 
degradation products depends on the ratio of 
the aliphatic to aromatic monomers. The glass 
transition temperatures for the P(CPP-SA) 
20:80 and the P(CPP-SA) 50:50 copolymers are 
47°C and 2°C respectively (Mathiowitz et al, 
1989). These are random polymers when the 
ratio of monomer is 1: 1 and the polymers tend 
to display block type distributions when either 
of the monomers is in excess (Ron et al, 1988). 
The polymers are semicrystalline with degrees 
of crystallinity ranging from 5 to 60% 
E. Mathiowitz, D. Kline, and R. Langer 
(Mathiowitz et al, 1988) . The various 
microencapsulation processes which were 
developed and/or employed were designed to 
address all these physical properties in such a 
way as to enable microspheres to be produced 
given nearly any polymer property and 
monomer composition. 
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In Vitro And In Vivo Morphological Studies Of 
Polyanhydride Microspheres 
a} Poiyanhydride microspheres prepared 
by the solvent evaporation technique. One of 
the oldest and most widely used methods of 
microsphere preparation is the solvent 
evaporation technique . Figure 2a is an SEM 
micrograph of the external surface of a P(CPP-
SA) 50: 50 polymer microsphere containing 5% 
(w/w) insulin. For this particular fabrication 
the initial polymer concentration was 0.05 
gr/ml of methylene chloride. The microspheres 
are spherical in shape and contain some pores 
on the surface (Figure 2b); a cross-sectional 
view of the microsphere reveals a very porous 
internal structure (Figure 2c) which is typical 
of this particular process. Porosity can be 
varied by changing the rate of solvent 
evaporation (via the temperature or stunng 
rate) as well as the concentration of the initial 
polymer solution. When the fabrication was 
repeated as above with an initial polymer 
concentration of 0 .20 g/ml of methylene 
chloride, the resulting microspheres showed a 
marked drop in porosity. 
In Vivo release . The microspheres were 
implanted inside diabetic rats and the blood 
glucose level was lowered precipitously for one 
day, with the majority of the rats dying due to 
insulin overdose. The porous structure of the 
spheres would allow water to enter the sphere 
quickly and lead to complete insulin release in 
a short period of time, which may explain the 
extremely fast and generally fatal 
hypoglycemia that was observed. 
Besides resulting in high microsphere 
porosity, sol vent evaporation also accelerates 
polymer degradation during the first stages of 
preparation due to the presence of the water 
phase . For these reasons, other fabrication 
methods to make slower-releasing and longer-
active polyanhydride microspheres were 
developed . 
Figure 2. a) External surface of P(CPP-SA) 
50:50 micro spheres made by solvent 
evaporation. Polymer concentration in 
methylene chloride was 0.05 g/ml. Size of 
microspheres was 100-200 µm. Bar=lO0 µm b) 
Higher magnification of a) revealing small 
pores in the external surface. Bar= 10 µm . c) 
Cross-section of the same microspheres 
revealing a very porous structure in the center 
and more dense structure close to the external 
surface. Bar= 50 µm 
Morphology of Po1 vanhydride Microsphere 
b) Polyanhydride microspheres prepared 
by hot melt microencapsulation: In this method 
we used polymer which had a relatively low 
melting point: P(CPP-SA) 20:80. Since in some 
cases the drug tends to precipitate on the 
external surface of the microspheres during the 
fabrication process, an external analysis of 
drug-loaded microspheres was very important. 
Figure 3a,b is an example of a P(CPP-SA) 20:80 
microsphere loaded with 40% (w / w) 
acetylsalicylic acid. As can be seen, some of the 
drug particles coat the external surface of the 
microsphere. This type of microsphere could be 
useful if pulsatile release is needed, i.e., one 
would presumably obtain initially a fast, burst-
like dissolution of the external drug followed 
by the slower diffusional release of the internal 
drug. However, in most cases it is necessary to 
avoid the burst effect for reasons of toxicity , 
and this can be done by using small drug 
particle sizes as well as lower drug loadings. 
When 15% (w/w) loaded microspheres were 
prepared, using acetylsalicylic acid (or insulin) 
sieved to less than 50 µm, no sign of drug was 
observed on the external surface (Figure 4a). 
Microspheres obtained from this polymer by 
hot melt microencapsulation were spherical in 
shape (Figure 4a) . The external surface of these 
microspheres is dense and crenelated which is 
typical of the hot melt microencapsulation 
method (Figure 4a,b). 
In vitro release . Both blank and drug-
loaded microspheres prepared by hot melt 
microencapsulation were analyzed by SEM 
after in vitro degradation as described in 
Materials and Methods. The microspheres 
retained their structural integrity for only 
about 4 to 5 days. Cross-sections of the 
microspheres before degradation (Figure 4b) 
revealed a dense structure with a slightly more 
dense region at the surface. A cross-section of 
the microspheres after 15 hours (Figure 4c) 
showed a dense internal core surrounded by a 
well-defined erosion zone. This erosion zone 
advances, with time, from the outer surface of 
the device inwards . Measurement of the 
molecular weight distribution of the polymer 
during the first 2 days of degradation indicated 
that the internal core indeed consisted of 
unhydrolyzed polymer (Mathiowitz and Langer, 
1987). After 6 to 10 days of degradation, the 
microspheres tended to break apart 
completely. However, with care it was possible 
to remove isolated, fragile microspheres similar 
to the one shown in Figure 4d. Microspheres 
sampled at this time were only 3 to 5% of their 
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Figure 3. a) External surface of P(CPP-SA) 
20:80 microspheres, made by hot melt 
microencapsulation and loaded with 40% (w/w) 
acetylsalicylic acid Crystals on the surface are 
the drug particles (acetylsalicylic acid) that 
were not incorporated in the microsphere. Bar= 
2 0 0 µ m. b) The same as a) but higher 
magnification showing the crystals close to the 
polymer external surface. Bar= 10 µm . 
initial weight and when cross-sectioned (Figure 
4e) a very porous and brittle structure was 
observed . Analysis of the remains by infra red 
spectroscopy showed that the microspheres 
consisted of polymer degradation products that 
eventually disappeared in vitro at longer times. 
All of these results strongly indicate that the 
release process is dominated by surface 
erosion. 
The drug release and polymer 
degradation results from these in vitro studies 
supply further evidence supporting surface 
erosion as the controlling mechanism for 
E. Mathiowitz, D. Kline, and R. Langer 
334 
Figure 4. SEM of a P(CPP-SA) 20:80 
micro sphere made by hot melt 
microencapsulation. a) External surface of 
insulin loaded microspheres(l 5 %loading). (From 
Mathiowitz E, Langer R. (1987). Journal of 
Controlled Release. .5.., 13-22. With permission) 
Note the smooth butcrenelated external 
surface. Bar= 50 µm. b) Cross-section of blank 
microsphere before degradation. Note the 
dense internal structure . Bar= 100 µm. c) cross 
section of blank microsphere, 15 hr after start 
of degradation. A well-defined eroding zone 
exist which surrounds an internal intact zone. 
Bar= l00µm. d) External surface of blank 
microsphere 10 days after degradation. Bar= 
l0Oµm. e) Cross-section of a sphere 10 days 
after degradation. Note the fragile structure 
which is composed only of monomeric 
degradation products. Bar=500µm. 
Morphology of Polyanhydride Microsphere 
25 
Time (hours} 
• Acid Orange 27 % 
■ Polymer 27% 
o Acid Orange 2 % 
o Polymer 2% 
50 
Figure 5 . Pol ymer degrad ation and acid 
orange release from P(CPP-SA)20 :80 
micro sphere s made by hot melt 
microencapsulation (size: 800-1 ,000µm) for 
both 2% and 27% (w/w) loadings . (From 
Mathiowitz E , Langer R.(1987) . Journal of 
Controlled Release 5.., 13 -
22. With permiss ion) 
release from microspheres made by hot melt 
microencap sulation . The relation between 
polymer degradation and drug release in these 
micro spheres was a strong function of the drug 
loading (Figure 5) . When low loadings (-2%) of 
very hydrophilic drugs such as acid orange 
were used (Figure 5) , the drug release and 
polymer erosion profiles were very similar, 
which was characteristic of release controlled 
by surface erosion . The explanation for this 
behavior was as follows : at low loading each 
drug particle was completely surrounded by 
polymer, so drug dissolution and release was 
not possible until the surrounding polymer has 
been degraded . As drug loading was increased, 
the particles were no longer isolated but 
instead formed a connected network of pores 
through which water could enter and dissolve 
the drug. As the results for 27% loaded devices 
in Figure 5 demonstrate, release at high drug 
loadings was controlled by diffusion through 
the drug-formed pores in the microsphere 
(Saltzman et al., 1987), rather then release due 
to erosion of the surrounding polymer. When 
more hydrophobic drugs , such as Zn-insulin, 
were incorporated, a nice correlation between 
drug release and polymer ewsion occurred 
(Mathiowitz and Langer, 1987). 
In Vivo de~radation. Blank microspheres 
composed of P(CPP-SA) 20:80 and made by hot 
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Figure 6. Cross-section of P(CPP-SA) 20: 80 
micro sphere (made by hot melt 
microencapsulation) after 6 days of in vivo 
degradation. Note the porous internal structure 
and the dense structure near the external 
surface . Bar= lO0µm. 
melt microencapsulation were implanted 
subcutaneously in rats . These were relatively 
large microspheres ranging from 800 to 1000 
µm in diameter. Tissue samples of the 
implantation site were removed at 
predetermined times. Since the larger P(CPP-
SA) 20:80 microspheres could be easily 
removed from the tis sue , one of them was 
taken from the day 6 sample and analysed by 
SEM. It was still spherical in shape, although 
very soft, and weighed only 6% of its initial 
weight. The sphere was freeze-dried and cross-
sectioned for analysis , which caused it to 
collapse from its original spherical shape. The 
cross-sectional view is shown in Figure 6. The 
external surface of the sphere, which directly 
interacted with the living tissue, seems to be 
similar to that obtained for blank microspheres 
degrading in vitro (Figure 4c), while the 
material from the inner core has already been 
degraded. It is important to note that 
microspheres that were taken out of the tissue 
one or 2 days after implantation still contained 
an intact core, as was also found in the in vitro 
studies. Furthermore, the micro spheres 
disappeared completely in vivo at longer times, 
as they did in vitro. 
In vivo release. The effect of a less 
porous internal morphology on release profiles 
was also seen in vivo . When P(CPP-SA) 20:80 
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Figure 7. Urine (a) and blood (b) glucose 
levels of diabetic rats either untreated (control) 
or implanted with insulin-loaded P(CPP-SA) 
20:80 microspheres on the 4th and 2nd days 
(treated). Microspheres were made by the hot 
melt technique with an insulin loading of 15% 
(w/w). Size of microspheres: 800-1000 µm. 
Control animals were diabetic rats. (From 
Mathiowitz E, Langer R. (1987). Journal of 
Controlled Release .5.., 13-22. With permission) 
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microcapsules loaded with 15% (w/w) Zn-
insulin were prepared by hot melt 
microencapsulation and implanted into diabetic 
rats, normoglycemia was achieved for 3-4 days 
(Figure 7a-b) with no deaths due to insulin 
overdose. This stands in stark contrast to the 
microspheres made by solvent evaporation, 
which caused short-lived, often fatal 
hypoglycemia . 
While the hot melt fabrication method 
has certain advantages as demonstrated by in 
vivo and SEM analysis, many drugs lose 
biological act1v1ty at high temperature. 
Therefore, this technique can only be used with 
low melting point polymers. This fact 
encouraged us to develop a less drastic method 
which is similar to solvent evaporation but 
lacks the aqueous phase which initiates 
polymer hydrolysis . 
c) Polyanhydride microspheres prepared 
by solvent removal: This method, based on 
sol vent evaporation, offers several significant 
advantages over previously discussed 
fabrication techniques, i.e ., the process occurs 
at room temperature and in the complete 
absence of water. The latter advantage is 
particularly important for hydrolytically labile 
polymers such as polyanhydrides. Copolymers 
of CPP copolymerized with sebacic acid or 
dodecanedioic acid (DD) at a molar ratio of 
50:50 were used for this method. In general, 
the microspheres were spherical in shape 
(Figure 8) with a dense outer surface but a 
porous internal structure (see for example 
Figure 9). The P(CPP-SA) 50:50 microspheres 
(Figure 9) displayed slight porosity, whereas 
the porosity of the P(CPP-DD) 50:50 spheres 
was significantly lower (Mathiowitz et al., 
1988). The formation of a porous structure 
inside and a dense structure outside may be 
due to precipitation occurring first on the outer 
surface of the sphere during fabrication. Once 
the external surface precipitates, the internal 
core still contains methylene chloride; from 
that stage on, no decrease in the microsphere 
size or shrinking of the structure will occur, 
even as the remaining solvent diffuses out. 
In vivo degradation. Blank P(CPP-SA) 
50:50 microspheres prepared by solvent 
removal were implanted subcutaneously in 
rats. The spheres were smaller then 300 µm 
and were thus injected as an aqueous 
suspension. After 10 days of implantation 
several spherical microsphere remnants were 
found among the remains of degraded 
microspheres in tissue samples taken from the 
Morphology of Polyanhydride Microsphere 
Figure 8. SEM of external surface of P(CPP-
SA) 50:50 microspheres made by solvent 
removal technique. Note the dense external 
surface of the microspheres. Bar= IO µm. 
implantation site. These remnants were 
composed of the same polymer degradation 
products as seen in the non-intact remnants (as 
judged by IR spectroscopy) and eventually 
disappeared from the implantation area. As 
previously noted, spherical remnants of the 
external surface were also seen in vivo with 
degrading blank microspheres made by the hot 
melt microencapsulation method. 
Although the appearance of external 
remnants might, at first glance, appear to 
contradict other evidence supporting surface 
erosion, the SEM analysis of microspheres 
already presented suggests a possible 
explanation based on polymer density. Cross-
sections of microspheres during release (Figure 
4b) show an outer zone in which degradation 
has already occurred but the degradation 
products have not yet disappeared. In addition, 
cross-sectional views of undegraded 
microspheres made by both solvent removal 
(Figure 9) and hot melt microencapsulation 
(Figure 4a) show a dense external surface and a 
less dense inner core. It is quite plausible that 
during degradation the external surface erodes 
completely, leaving behind a dense but 
permeable layer of degradation products that 
must dissolve and diffuse away. Meanwhile, 
erosion continues into the core, where the 
degraded material is less dense and is able to 
more easily solubilize and diffuse out. The fact 
337 
Figure 9. Cross-section of the same 
microspheres as in Figure 8. Bar= 50 µm.(From 
Mathiowitz et al. (1988). Journal of Applied 
Polymer Sciences li, 755-774. With 
permission). Note the semi porous structure in 
the core compared to the denser structure near 
the external surface 
that the remnants disappear at longer times in 
vivo is further evidence that solubilization of 
the degradation products may be the 
controlling step in the disappearance of the 
microspheres, but Il.Q.1_ in the release of the 
drug. 
In vivo release. An in vivo study with 
insulin-loaded microspheres prepared by the 
solvent removal method demonstrated serum 
and urine glucose control much more successful 
than that previously seen with microspheres 
made by sol vent evaporation. Five diabetic 
rats were implanted with 200 mg of 
microspheres containing insulin at a 10% (w/w) 
loading. As the results in Figure 10 
demonstrate, five days of near-zero unne 
glucose levels and four days of serum glucose 
control were achieved. A similar experiment 
with 200 mg of 5% (w/w) loaded microspheres 
decreased urine glucose effectively for three 
days and resulted rn only one day of 
normoglycemia, while 100 mg of 10% (w/w) 
loaded microspheres showed three days of 
lowered urine glucose and two days of serum 
glucose control. For comparison, urine and 
blood glucose levels for both diabetic control 
and healthy control rats (five rats in each 
group) were measured. As expected, glucose 
was never found in the urine of healthy rats, 
and the untreated diabetic rats showed no 
significant lowering of blood or urine glucose 
E. Mathiowitz, D. Kline, and R. Langer 
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Figure 10. Blood (a) and urine (b) glucose 
levels of diabetic rats implanted with 10 % 
(w/w) Zn-insulin-loaded P(CPP-SA) 50:50 
microspheres (sol vent removal method) on day 
0 ; size of microspheres was 50-300 µm . (From 
Mathiowitz et al. (1988). Journal of Applied 
Polymer Sciences ll, 755-774 . With 
permission) 
levels (Figure 10). 
In vitro release. In addition, the 10% 
(w/w) loaded microspheres show a good 
correlation between the 1n vivo glucose 
measurements discussed in the previous 
paragraph and in vitro release results . This 
system resulted in a decrease in urine glucose 
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Figure 11. Insulin released from P(CPP-SA) 
50:50 microspheres, 10% (w/ w) loading 
prepared by sol vent removal. (From 
Mathiowitz et al. ( 1988). Journal of Applied 
Polymer Sci e nces li, 755-774 . With 
permission) 
near normal serum glucose levels for four days. 
In comparison , the in vitro result s showed five 
to six days of insulin release (Figure 11 ). In a 
s imilar set of studi es, in sulin-loaded 
micro spheres prepared by solvent removal 
cau sed a longer-lasting normoglycemia than 
c orre s ponding hot melt micro s pheres 
(Mathiowitz and Langer, 1987) , even though 
the former were much smaller (less than 300 
µm) and would be expected to release insulin 
more quickly . This may be explained by the 
fact that the microspheres prepared by solvent 
removal were made of a more hydrophobic 
polymer which degraded more slowly. 
d) General comments. The in vivo 
treatments discussed above are limited to a 
short term release of insulin, that is, periods of 
time that range between one day and one 
week. However , even this can be an 
improvement over a daily injection of insulin 
required by many diabetic patients. Longer 
insulin delivery times can presumably be 
achieved by using polymers which are more 
hydrophobic and more crystalline. 
The advantage of the several fabrication 
methods described is that they allow polymers 
and drugs of widely varying physical 
properties to be used to make microspheres. 
The hot melt method is carried out close to the 
polymer melting point, which limits it to low 
Morphology of Polyanhydride Microsphere 
melting point polymers; however, the great 
advantage of this method is the elimination of 
organic solvents that may inactivate protein 
drugs. The solvent removal technique, although 
carried out in organic sol vents, provides for 
room temperature microsphere formation for 
polymers of any melting point without 
hydrolytic degradation of the polymer or 
dissolution of water soluble drug. Solvent 
evaporation, though not useful here because of 
the hydrolytic instability of polyanhydrides, is 
applicable for more stable polymers in which 
lipophilic drugs are being incorporated. 
Summary 
The goal of this paper was to show that by 
the judicious use of SEM in conjunction with 
conventional release studies, an understanding 
of how to achieve well-defined delivery 
systems suitable for a given polymer/drug pair 
can be obtained. Although this study was 
confined to the development of a continuous, 
short-term drug delivery system, the 
applicability of SEM analysis can be envisioned 
for other desired release profiles, e.g. systems 
that display a pulsatile release . Alternating 
shells of fast and slow degrading polymer in a 
microsphere might be a way to achieve this 
goal, and morphological studies using the 
techniques described here are likely to be of 
utility in ensuring that the desired degradation 
behavior is indeed occurring . 
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Discussion with Reviewers 
A.J. Wassermann: You suggest 1n the 
manuscript that the anhydride bond of the 
polyanhydride microsphere is hydrolyzed. 
Presumably this occurs post-implantation, 1n 
the tissues, and is the mechanism of 
microsphere erosion and drug release. 
However, was an inflammatory response 
present in the tissue when the microspheres 
were removed? Is it possible that phagocytosis 
and hydrolytic enzymes of inflammatory cells 
contribute to microsphere erosion and 
consequently drug release? 
Authors: The mechanism of in vivo erosion of 
microspheres presumably does involve 
phagocytosis. In a recent work by Tamarago et 
al. (1989) this issue was discussed in more 
detail (in their case slabs were implanted in the 
brains of rats). In our case, preliminary results 
do reveal that macrophages are involved in the 
process and, of course, they must influence the 
polymer degradation in vivo, but more work is 
needed to study this phenomenon. 
Y. Talmon: What were the criteria for particle 
size selection in this study, and how much 
control on particle size do the three techniques 
give? 
Authors: This is a good question. With both hot 
melt and solvent evaporation techniques, the 
size was determined mostly by the stirring 
rate . With these methods, one can form 
microspheres ranging from 1 to 1000 microns 
in diameter. With the solvent removal method 
it was possible to get microspheres smaller 
than 300 microns. For more information, the 
reader is referred to the two specific papers 
which describe the preparation of these 
microspheres in more detail (Mathiowitz and 
Langer 1987, Mathiowitz et al., 1988). 
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M.A. Wheatley: Can you comment on the 
relationship between size and degradation 
profile? 
Authors: As a general rule, if we take the same 
preparation method, let's assume hot melt, and 
vary only the size of the microspheres, the 
degradation of smaller microspheres will be 
much faster than that of larger ones. For more 
details, the readers are referred to the specific 
paper which discuss this phenomenon 
(Mathiowitz and Langer 1987, Mathiowitz et al., 
1988). The purpose of this work was to 
demonstrate that other properties, like 
morphology, are also very important and may 
influence degradation rate. 
